Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 Feb 26;30(2):92–94. doi: 10.1002/clc.20006

Falsely Elevated Cardiac Troponin I Levels

Amgad N Makaryus 1,, Mary N Makaryus 1, Babak Hassid 2
PMCID: PMC6653083  PMID: 17326064

Abstract

The measurement of cardiac troponins (cTn) is of considerable usefulness in the diagnosis of acute coronary syndrome. Abnormal levels of serum cTn are occasionally found in patients who are not suffering a myocardial infarction. This may be observed in several well‐known situations including pulmonary embolism, pericarditis, myocarditis, coronary vasospasm, sepsis, congestive heart failure, supraventricular tachycardia with hemodynamic compromise, re‐nal insufficiency, and prolonged strenuous endurance exercise. Endogenous antibodies such as heterophile antibodies, rheumatoid factor, and other autoantibodies are known to interfere with the immunoassay measurements of many different analytes, including the widely used Abbot AxSYM™ cTnI analyzer. Other sources of circulating antibodies include immunotherapies, vaccinations, or blood transfusions that may interfere with these immunoassays as well. We examine the case of a 48‐year‐old man with a history of hypercholesterolemia and obesity who presented with chest pain and was found to have elevated Tn I levels on two separate occasions. Further work‐up revealed that the Tn I levels were spuriously elevated because the patient's blood revealed a normal cTnI level when mixed with polyethylene glycol to inactivate any antibodies interfering with the cTnI assay.

Keywords: troponin, acute coronary syndrome, laboratory testing

Full Text

The Full Text of this article is available as a PDF (213.2 KB).

REFERENCES

  • 1. Ng SM, Krishnaswamy P, Morrisey R, Clopton P, Fitzgerald R, et al.: Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. Am J Cardiol 2001;87 8:994–999;A4 [DOI] [PubMed] [Google Scholar]
  • 2. Donnino MW, Karriem‐Norwood V, Rivers EP, Gupta A, Nguyen HB, et al.: Prevalence of elevated troponin I in end‐stage renal disease patients receiving hemodialysis. Acad Emerg Med 2004;11 9:979–981 [DOI] [PubMed] [Google Scholar]
  • 3. Needham DM, Shufelt KA, Tomlinson G, Scholey JW, Newton GE: Troponin I and T levels in renal failure patients without acute coronary syndrome: A systematic review of the literature. Can J Cardiol 2004;20 12:1212–1218 [PubMed] [Google Scholar]
  • 4. Tanasijevic MJ, Antman EM: Diagnostic performance of cardiac troponin I in suspected acute myocardial infarction: Implications for clinicians. Am Heart J 1999;137:203–206 [DOI] [PubMed] [Google Scholar]
  • 5. Kenny PR, Finger DR: Falsely elevated cardiac troponin‐I in patients with seropositive rheumatoid arthritis. J Rheumatol 2005;32 7:1258–1261 [PubMed] [Google Scholar]
  • 6. Knoblock RJ, Lehman CM, Smith RA, Apple FS, Roberts WL: False‐positive AxSYM cardiac troponin I results in a 53‐year‐old woman. Arch Pathol Lab Med 2002;126 5:606–609 [DOI] [PubMed] [Google Scholar]
  • 7. Katwa G, Komatireddy G, Walker SE: False positive elevation of cardiac troponin I in seropositive rheumatoid arthritis. J Rheumatol 2001;28 12:2750–2751 [PubMed] [Google Scholar]
  • 8. Fitzmaurice TF, Brown C, Rifai N, Wu A, Yeo KTJ: False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998;44:2212–2214 [PubMed] [Google Scholar]
  • 9. Adams JE, Miracle VA: Cardiac biomarkers: Past, present, and future. Am J Crit Care 1998;7:418–425 [PubMed] [Google Scholar]
  • 10. Olatidoye AG, Wu AHB, Feng YJ, Waters D: Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta‐analysis comparing published studies. Am J Cardiol 1998;81:1405–1410 [DOI] [PubMed] [Google Scholar]
  • 11. Wright SA, Goldhaber SZ: Nonspecific elevation of troponin I. ACC Curr J Rev 1998;7 6:29–31 [Google Scholar]
  • 12. Wu AHB, Feng YJ, Moore R, Apple FS, McPherson P, et al.: Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 1998;44:1198–1208 [PubMed] [Google Scholar]
  • 13. Lewis JS Jr, Taylor JF, Miklos AZ, Virgo KS, Creer MH, et al.: Clinical significance of low‐positive troponin I by AxSYM and ACS:180. Am J Clin Pathol 2001;116:396–402 [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES